# Review of FEXP_ANON_149

**Overall Score:** **2.3 / 10.0** (Fundamentally Invalid) | **Scientific Core Score:** **1.7 / 8.0**  
* **Score Breakdown:** Rigor: 0.5/3.5 | Claims: 0.4/2.5 | Biology: 0.8/2.0 | Reproducibility: 0.6/2.0

---

## 1. Blinded Metadata Perception

* **Anonymized Manuscript ID:** `FEXP_ANON_149`
* **Perceived Field & Subfield:** Synthetic Organic / Textile Dye Chemistry & Antimicrobial Pharmacology (Azo Quinazolinone Disperse Dyes, Polyester Dyeing/UPF Characterization, In Vitro Antimicrobial Assays, and Molecular Docking).
* **Study Design Type:** Experimental chemical synthesis and spectroscopic characterization of six azo-quinazolinone dyes (`4a–c`, `5a–c`), polyester dyeing and fastness/colorimetric ($K/S$, CIELAB, UPF) testing, disk-diffusion and broth-dilution antimicrobial assays, and Molegro Virtual Docker / SwissADME computational modeling.

---

## 2. Executive Summary & Editorial Verdict

The authors report the synthesis of six azo-quinazolinone disperse dyes (`4a–c` and `5a–c`), evaluate their UV-Vis absorption spectra and polyester dyeing properties (washing/rubbing/perspiration/sublimation/light fastness, CIELAB coordinates, color strength $K/S$ across pH, time, and concentration, and ultraviolet protection factor UPF), test their antimicrobial activity against four bacterial and two fungal strains, and dock compounds `5b` and `5c` into *E. coli* DNA gyrase (PDB ID: `5L3J`) alongside SwissADME profiling.

**Editorial Verdict: Reject (Fundamentally Invalid, 2.3 / 10.0).** The manuscript contains a complete inversion between its experimental antimicrobial data and its computational/mechanistic narrative, alongside severe chemical characterization anomalies and out-of-context boilerplate text. Specifically, in the Abstract, Docking section (line 330), and SAR section, the authors claim that **`5b` is the most potent antibacterial compound** and **`5c` is the least active compound**, and use molecular docking ($\Delta G_{\text{bind}} = -10.32\text{ kcal/mol}$ for `5b` vs. $-7.86\text{ kcal/mol}$ for `5c`) to explain why `5b` outperforms `5c`. However, in the experimental antimicrobial tables (Table 13 and Table 14) and text (lines 401, 406), **`5b` is the LEAST active compound in the entire series** (inhibition zones $9\text{--}14\text{ mm}$; $\text{MIC} = 84\text{--}94\text{ }\mu\text{M}$), whereas **`5c` is the MOST potent compound in the entire series** (inhibition zones $15\text{--}21\text{ mm}$; $\text{MIC} = 35\text{--}47\text{ }\mu\text{M}$)! Furthermore, the analytical data exhibit identical duplicated "Found" elemental analysis numbers across regioisomer pairs (`4a` = `4b` and `5a` = `5b`), a $1.70\%$ carbon elemental error for `5c`, inconsistent $K/S$ measurements across tables for the same dye, misclassification of *Bacillus subtilis* as a Gram-negative bacterium, and spliced boilerplate paragraphs about bacteriophage CBASS immunity and protein–protein interaction (PPI) inhibitors.

### Specific Conclusions and Assessment of Support

* **Experimental antimicrobial data align with molecular docking showing that `5b` is the most active antibacterial compound ($-10.32\text{ kcal/mol}$) while `5c` has low antibacterial efficacy ($-7.86\text{ kcal/mol}$): [Methodologically Flawed].**  
  Tables 13 and 14 show the exact opposite: across all six tested microorganisms (*E. coli*, *P. aeruginosa*, *S. aureus*, *B. subtilis*, *C. albicans*, and *A. flavus*), `5c` is the **most potent** compound ($\text{IZ} = 15\text{--}21\text{ mm}$, $\text{MIC} = 35\text{--}47\text{ }\mu\text{M}$), while `5b` is the **least active** compound ($\text{IZ} = 9\text{--}14\text{ mm}$, $\text{MIC} = 84\text{--}94\text{ }\mu\text{M}$). The entire docking and SAR section is built on an inverted activity assignment.

* **Compounds `4a–c` and `5a–c` were synthesized in high purity and verified by elemental analysis, NMR, FT-IR, and MS: [Fragile].**  
  Compound `5c` fails elemental combustion criteria by $1.70\%$ in carbon (`Calcd C, 75.43%; Found C, 77.13%`, line 72). Regioisomers `4a` and `4b` report identical experimental CHN percentages to two decimal places (`C, 74.03%; H, 4.63%; N, 15.16%`), as do `5a` and `5b` (`C, 70.67%; H, 4.57%; N, 17.53%`). In $^1\text{H}$ NMR (lines 47, 52), the $-\text{NH}_2$ singlet of `4a` and `4b` integrates to `1H` instead of `2H`, leaving 25 protons instead of 26 for $\text{C}_{34}\text{H}_{26}\text{N}_6\text{O}_2$.

* **Dyeing optimization on polyester shows consistent color strength ($K/S$) trends across pH, dyeing time, and dye concentration: [Fragile].**  
  The $K/S$ values reported for the same dye under standard conditions (`2% owf, 130 °C, 60 min`) contradict one another across tables: for dye `5c`, $K/S$ is `2.27` in Table 6, `1.78–2.39` across all pH values in Table 7, `12.67` at 60 min in Table 8, and `4.62` at 2% owf in Table 9.

---

## 3. Forensic Defect Inventory

### 1. Complete Inversion of Active (`5c`) and Inactive (`5b`) Compounds Between Wet-Lab Tables and Docking/SAR Text
* **Location:** Abstract (line 5), Section *In silico docking investigations* (line 330), Table 11, Table 13 (lines 388–400), Table 14 (lines 409–418), and Section *SAR* (second chunk, line 7).
* **Defect:** Line 330 states: *"To determine the binding mode of interactions and to create the ideal conformation of the most active molecule (5b) and the least active one (5c), molecular docking analysis was used. While compound 5c only has a low antibacterial efficacy, compound 5b has a high antibacterial potency..."* However, in Table 13, `5b` has the smallest inhibition zones of any compound (`9–14 mm`) while `5c` has the largest (`15–21 mm`). In Table 14, `5b` has near-inactive MICs (`84–94 µM`) while `5c` has the lowest MICs of all six compounds (`35–47 µM`). Thus, the docking scores (`5b = −10.32` vs. `5c = −7.86`) are negatively correlated with the actual experimental bioactivity, directly refuting the Abstract and SAR conclusions.

### 2. Spliced Out-of-Context Boilerplate (Bacteriophage CBASS Immunity and Protein–Protein Interaction Inhibitors)
* **Location:** Section *In silico docking investigations* (line 330) and Section *ADMET features* (line 369).
* **Defect:**
  1. Line 330 opens the DNA gyrase docking section with an unrelated paragraph about bacteriophage immunity: *"Bacteria have numerous defenses against foreign invaders, including a widely distributed bacteriophage defensive system called CBASS (cyclic oligonucleotide-based anti-phage signaling system). A cGAS/DncV-like nucleotidyl transferase in CBASS systems responds to infection by producing cyclic di- or trinucleotide second messengers."* CBASS has nothing to do with *E. coli* DNA gyrase or azo disperse dyes.
  2. Line 369 states: *"Moreover, the elevated log p values observed in compound 5c represent intentional and strategic design features as the disruption of protein–protein interactions (PPIs) requires compounds with sufficient lipophilicity to engage effectively with the large hydrophobic interface's characteristic of this challenging target class."* Compound `5c` is not even included in Table 12 (which only lists `5b` and three control antibiotics), and the study does not target any protein–protein interaction.

### 3. Elemental Analysis Duplications, Combustion Failure for `5c`, and $^1\text{H}$ NMR Integration Errors
* **Location:** Experimental section (lines 45–73) and Results (line 133).
* **Defect:**
  1. **1.70% carbon error in `5c`:** For `5c` ($\text{C}_{32}\text{H}_{23}\text{N}_5\text{O}_2$), calculated C is $75.43\%$, but found C is $77.13\%$ ($\Delta = +1.70\%$, more than $4\times$ the $\pm 0.40\%$ analytical threshold for purity).
  2. **Identical CHN values across distinct isomers:** `4a` (line 47) and `4b` (line 52) report identical found CHN values (`C, 74.03%; H, 4.63%; N, 15.16%`). Similarly, `5a` (line 62) and `5b` (line 67) report identical found CHN values (`C, 70.67%; H, 4.57%; N, 17.53%`).
  3. **Missing proton in $^1\text{H}$ NMR of `4a` and `4b`:** Both `4a` and `4b` report `8.69 (s, 1H, NH2)`, integrating a two-proton $-\text{NH}_2$ group as `1H` (totaling 25 H instead of 26 H).
  4. **False NMR claim for `4c` and `5c`:** Line 133 states that the $^1\text{H}$ NMR spectra of `4a–c` and `5a–c` all display exchangeable $-\text{NH}_2$ peaks, overlooking that `4c` and `5c` are 2-hydroxynaphthyl derivatives lacking any $-\text{NH}_2$ group.
  5. **Electronic substituent inversion:** Line 176 describes the hydroxyl ($-\text{OH}$) and naphthyl groups of `4c` and `5c` as *"Strong electron-accepting groups"*, contradicting basic organic chemistry and Introduction line 19 (which correctly identifies $-\text{OH}$ as an electron-donating group).

### 4. Mutually Inconsistent Color Strength ($K/S$) Data Across Tables 5–9 and Empty/Mislabeled Tables
* **Location:** Table 2 (line 184), Tables 5–6 (lines 225–240), Table 7 (lines 255–264), Table 8 (lines 276–285), and Table 9 (lines 295–304).
* **Defect:**
  1. For dye `5c` at 60 min, Table 8 reports $K/S = 12.67$ (and $12.0$ at 45 min), whereas Table 6 reports mean $K/S = 2.27$, Table 7 reports $K/S = 1.43\text{--}2.39$ across all pH values (pH 3–11), and Table 9 reports $K/S = 4.62$ at 2% owf and $6.94$ at 3% owf. Similar incompatibilities occur for `5a` ($K/S = 5.96$ in Table 8 vs. $1.98$ at 2% owf in Table 9) and `4a` ($K/S = 2.37$ in Table 6 vs. $1.00$ at 2% owf in Table 9).
  2. Table 2 (line 184) is completely blank, and Table 9 (line 295) is mistitled *"Effect of pH on the color strength (K/S)"* when its columns are dye concentrations (`0.5%, 1%, 2%, 3%`).

### 5. Microbiological Misclassifications and Experimental Protocol Errors
* **Location:** Section *Evaluation of the antimicrobial action* (lines 126–128) and Section *Antimicrobial activity* (lines 401, 406).
* **Defect:**
  1. Line 401 classifies *Bacillus subtilis* as a Gram-negative bacterium (*"disclosed very good activities for Gram-negative bacteria (B. subtilis)"*). *B. subtilis* is a canonical Gram-positive rod.
  2. Line 406 refers to *Aspergillus flavus* as `"C. flavus"`.
  3. Line 126 states that *"Standard-sized (5 cm) Whatman filter paper discs were cut"*—a $5\text{ cm}$ ($50\text{ mm}$) disc exceeds all measured inhibition zones ($9\text{--}27\text{ mm}$ in Table 13); standard antibiotic susceptibility discs are $5\text{--}6\text{ mm}$.
  4. Line 127 states *"The following formula was used to determine the complex's percentage activity index:"* followed by a blank line with no formula and no activity index values reported anywhere in the paper.

---

## 4. Quantitative Rubric Scoring

| Rubric Dimension | Score | Max | Forensic Justification |
| :--- | :---: | :---: | :--- |
| **1. Methodological & Statistical Rigor** | **0.5** | **3.5** | Complete inversion of `5b` (least active) and `5c` (most active) between wet-lab antimicrobial tables and docking/SAR analysis; mutually contradictory $K/S$ measurements across Tables 5–9; arbitrary Molegro scores reported as $\text{kcal mol}^{-1}$. |
| **2. Claim-to-Evidence Alignment** | **0.4** | **2.5** | Abstract and SAR claim experimental antimicrobial data match docking of `5b` as the most potent inhibitor, when Tables 13–14 show `5b` is the weakest compound and `5c` is the strongest; spliced CBASS and PPI-inhibitor boilerplate. |
| **3. Data Integrity & Biological Plausibility** | **0.8** | **2.0** | $1.70\%$ carbon elemental error for `5c`; duplicated CHN combustion numbers for `4a`/`4b` and `5a`/`5b`; $-\text{NH}_2$ integrated as 1H in `4a`/`4b`; *B. subtilis* misclassified as Gram-negative; $-\text{OH}$ called a strong electron-accepting group. |
| **4. Reproducibility & Data Integrity** | **0.6** | **2.0** | Missing equation in line 127; blank Table 2; mislabeled Table 9 header; $5\text{ cm}$ vs. $5\text{ mm}$ disc typo; `THPA336` residue typo in Table 11. |
| **Scientific Core Score** | **1.7** | **8.0** | Sum of Rigor + Claims + Biology. |
| **Total Composite Score** | **2.3** | **10.0** | **Fundamentally Invalid Tier (1.0 – 2.9).** |
